Charitable medication distribution improves care for uninsured patients with diabetes
CONCLUSIONS: Our results showed a significant improvement in glycemic control among participants, demonstrating the substantial impact that pharmacies partnered with charitable medication distributors such as the Dispensary of Hope can have on individuals with insulin-treated T2D.PMID:37948644 | DOI:10.37765/ajmc.2023.89453 (Source: The American Journal of Managed Care)
Source: The American Journal of Managed Care - November 10, 2023 Category: Health Management Authors: Jonathan Hughes Abby Sparkman Priscilla Smith Tim McCormack Tavajay Campbell Hillary Blackburn Source Type: research
Charitable medication distribution improves care for uninsured patients with diabetes
CONCLUSIONS: Our results showed a significant improvement in glycemic control among participants, demonstrating the substantial impact that pharmacies partnered with charitable medication distributors such as the Dispensary of Hope can have on individuals with insulin-treated T2D.PMID:37948644 | DOI:10.37765/ajmc.2023.89453 (Source: The American Journal of Managed Care)
Source: The American Journal of Managed Care - November 10, 2023 Category: Health Management Authors: Jonathan Hughes Abby Sparkman Priscilla Smith Tim McCormack Tavajay Campbell Hillary Blackburn Source Type: research
Charitable medication distribution improves care for uninsured patients with diabetes
CONCLUSIONS: Our results showed a significant improvement in glycemic control among participants, demonstrating the substantial impact that pharmacies partnered with charitable medication distributors such as the Dispensary of Hope can have on individuals with insulin-treated T2D.PMID:37948644 | DOI:10.37765/ajmc.2023.89453 (Source: The American Journal of Managed Care)
Source: The American Journal of Managed Care - November 10, 2023 Category: Health Management Authors: Jonathan Hughes Abby Sparkman Priscilla Smith Tim McCormack Tavajay Campbell Hillary Blackburn Source Type: research
Charitable medication distribution improves care for uninsured patients with diabetes
CONCLUSIONS: Our results showed a significant improvement in glycemic control among participants, demonstrating the substantial impact that pharmacies partnered with charitable medication distributors such as the Dispensary of Hope can have on individuals with insulin-treated T2D.PMID:37948644 | DOI:10.37765/ajmc.2023.89453 (Source: The American Journal of Managed Care)
Source: The American Journal of Managed Care - November 10, 2023 Category: Health Management Authors: Jonathan Hughes Abby Sparkman Priscilla Smith Tim McCormack Tavajay Campbell Hillary Blackburn Source Type: research
Charitable medication distribution improves care for uninsured patients with diabetes
CONCLUSIONS: Our results showed a significant improvement in glycemic control among participants, demonstrating the substantial impact that pharmacies partnered with charitable medication distributors such as the Dispensary of Hope can have on individuals with insulin-treated T2D.PMID:37948644 | DOI:10.37765/ajmc.2023.89453 (Source: The American Journal of Managed Care)
Source: The American Journal of Managed Care - November 10, 2023 Category: Health Management Authors: Jonathan Hughes Abby Sparkman Priscilla Smith Tim McCormack Tavajay Campbell Hillary Blackburn Source Type: research
Charitable medication distribution improves care for uninsured patients with diabetes
CONCLUSIONS: Our results showed a significant improvement in glycemic control among participants, demonstrating the substantial impact that pharmacies partnered with charitable medication distributors such as the Dispensary of Hope can have on individuals with insulin-treated T2D.PMID:37948644 | DOI:10.37765/ajmc.2023.89453 (Source: The American Journal of Managed Care)
Source: The American Journal of Managed Care - November 10, 2023 Category: Health Management Authors: Jonathan Hughes Abby Sparkman Priscilla Smith Tim McCormack Tavajay Campbell Hillary Blackburn Source Type: research
The economic value of insulin glargine 300 U/mL (Gla-300) in people ≥18 years of age with type 2 diabetes mellitus: a value-based economic model from a U.S. payer perspective
CONCLUSIONS: The economic value of increased utilization of Gla-300 was driven by the reduction in HCRU, costs and market shares assumptions. Budgetary reductions were achieved by switching patients from long-acting BIs to Gla-300.PMID:37916295 | DOI:10.1080/13696998.2023.2277058 (Source: Journal of Medical Economics)
Source: Journal of Medical Economics - November 2, 2023 Category: Health Management Authors: Ekaterina Ponomareva Luke Schmerold Srinivas Sss Ronald Preblick Seojin Park Laura Wilson Andrew Revel Source Type: research
Glimepiride/Insulin-glargine
(Source: Reactions Weekly)
Source: Reactions Weekly - November 1, 2023 Category: Drugs & Pharmacology Source Type: research
Safety issues of tirzepatide (pancreatitis and gallbladder or biliary disease) in type 2 diabetes and obesity: a systematic review and meta-analysis
ConclusionBased on the currently available data, tirzepatide appears to be safe regarding the risk of pancreatitis. However, the increased risk of the composite outcome of gallbladder or biliary diseases observed in RCTs warrants further attention from physicians in clinical practice.Systematic review registrationhttps://www.crd.york.ac.uk/PROSPERO, identifier CRD42023412400. (Source: Frontiers in Endocrinology)
Source: Frontiers in Endocrinology - October 16, 2023 Category: Endocrinology Source Type: research
LIVE INDIA: Effectiveness of Gla-100 in a Post hoc Pooled Analysis of FINE ASIA and GOAL Registries
ConclusionIn routine clinical practice, Gla-100 significantly improved glycemic parameters after 6 months of treatment with a low risk of hypoglycemia and no weight change in participants with T2DM.Graphical Abstract (Source: Diabetes Therapy)
Source: Diabetes Therapy - October 4, 2023 Category: Endocrinology Source Type: research
Insulin Glargine is More Suitable Than Exenatide in Preventing Muscle
Loss in Non-Obese Type 2 Diabetic Patients with NAFLD
Conclusion Compared to exenatide, insulin glargine can relativity increase
PMA in patients with T2DM having BMI<28 kg/m2
and NAFLD. [...] Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, GermanyArticle in Thieme eJournals: Table of contents | Abstract | open access Full text (Source: Experimental and Clinical Endocrinology and Diabetes)
Source: Experimental and Clinical Endocrinology and Diabetes - October 4, 2023 Category: Endocrinology Authors: Liu, Lin Wang, Ruwen Gao, Jian Yan, Jianhua Zhang, Jingtian Zhang, Zhitian Liu, Jiaojiao Lin, Huandong Rao, Shengxiang Yao, Xiuzhong Wu, Weiyun Bian, Hua Wang, Xiangyu Guo, Shanshan Gao, Xin Yan, Hongmei Tags: Article Source Type: research
LIVE INDIA: Effectiveness of Gla-100 in a Post hoc Pooled Analysis of FINE ASIA and GOAL Registries
ConclusionIn routine clinical practice, Gla-100 significantly improved glycemic parameters after 6 months of treatment with a low risk of hypoglycemia and no weight change in participants with T2DM.Graphical Abstract (Source: Diabetes Therapy)
Source: Diabetes Therapy - October 4, 2023 Category: Endocrinology Source Type: research
